1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Specialties
Genex Pharmaceutical, Inc.

Genex Pharmaceutical, Inc.

GENX
Genex Pharmaceutical, Inc.US flagOther OTC
0.00
USD
- -
- -
1,788.00Market Cap
Genex Pharmaceutical, Inc.
GENX
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2003
2004
2005
2006
2007
TTM
FRC
- -
0.13
0.14
0.14
- -
0.18
Revenue per Share
- -
0.06
0.04
0.03
- -
0.02
Basic EPS, GAAP
- -
- -
0.08
0.07
- -
0.03
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.01
0.07
0.1
0.13
- -
0.14
Book Value per Share
- -
0.15
0.19
0.23
- -
0.27
Tangible Book Value per Share
11
18
18
18
- -
18
Basic Weighted Avg Shares
- -
2
2
2
3
3
Sales/Revenue/Turnover
-1,500.29
42.22
36.95
34.77
20.45
20.45
Operating Margin (%)
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
1
1
1
- -
- -
Net Income, GAAP
- -
- -
34.44
39.66
53.3
53.3
Effective Tax Rate (%)
-1,500.29
43.12
25.09
25.39
10.58
10.58
Profit Margin (%)
- -
2
3
- -
-1
-1
Working Capital
- -
- -
- -
- -
- -
- -
LT Debt
- -
3
3
4
5
5
Total Equity
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
41.34
30.53
14.25
14.25
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'07
Sep'07
Dec'07
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
18
18
18
Market Capitalization
4
8
5

Working Capital

FRC

•

in mil. unless spec.
Jun'07
Sep'07
Dec'07
Total Current Assets
7
8
2
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
6
7
- -
Inventories
- -
- -
- -
Total Current Liabilities
2
3
3
Payables & Accruals
2
2
3
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
16.55%
Free Cash Flow
- -
- -
-55.09%
Net Income, GAAP
- -
- -
-44.66%
Sales/Revenue/Turnover
- -
- -
32.77%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2005
- -
1
1
1
2
2006
1
1
1
1
2
2007
1
1
1
1
3

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2005
0.01
0.01
0.02
- -
0.04
2006
0.02
- -
0.01
- -
0.03
2007
0.01
0.01
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2005
- -
- -
- -
- -
- -
2006
- -
- -
- -
- -
- -
2007
- -
- -
- -
- -
- -
Similar Companies
Takara Bio Inc. (4974.T)
GKB Ophthalmics Limited (GKB.BO)
TransEnterix, Inc. (TRXDW)
Virtuoso Optoelectronics Limit (VOEPL.BO)
Edap Tms S.a. (EDAP)
Jiangsu Hanvo Safety Product Co., Ltd. (300952.SZ)
Business
Genex Pharmaceutical, Inc. is actively involved in the creation, manufacturing, and supply of Reconstituted Bone Xenograft (RBX) across the People's Republic of China. This specialized medical device is engineered to facilitate and enhance the bone regeneration process. Its composition, a precisely balanced blend of β-tricalcium phosphate and calcium sulfate hemihydrate, ensures it functions as a catalyst for osseous repair, fully absorbing and remodeling within twelve months without leaving behind foreign materials. The company provides its bone healing solutions to a network encompassing roughly 500 hospitals and various other medical equipment clients. Genex Pharmaceutical maintains its corporate headquarters in Tianjin City, within the People's Republic of China, and trades on the OTC market.

Company News

APIChatGPT

  • newsfilecorp.com

    Genix Pharmaceuticals Issues Clarification to Previously Announced Private Placement Terms

  • newsfilecorp.com

    Genix Pharmaceuticals Closes Private Placement